T1	PROC 46 77	Estudio multicéntrico y abierto
T2	CHEM 81 91	adalimumab
#1	AnnotatorNotes T2	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 97 136	evaluar la seguridad y la tolerabilidad
T4	CHEM 184 194	adalimumab
#2	AnnotatorNotes T4	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	DISO 222 238	colitis ulcerosa
#3	AnnotatorNotes T5	C0009324; Ulcerative Colitis; Disease or Syndrome
T6	PROC 296 327	Estudio multicéntrico y abierto
T7	CHEM 332 369	anticuerpo monoclonal anti-TNF humano
T8	CHEM 370 380	adalimumab
#4	AnnotatorNotes T8	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	PROC 386 425	evaluar la seguridad y la tolerabilidad
T10	CHEM 473 483	adalimumab
#5	AnnotatorNotes T10	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	DISO 511 527	colitis ulcerosa
#6	AnnotatorNotes T11	C0009324; Ulcerative Colitis; Disease or Syndrome
T12	DISO 586 602	Colitis ulcerosa
#7	AnnotatorNotes T12	C0009324; Ulcerative Colitis; Disease or Syndrome
T13	PROC 713 722	protocolo
#8	AnnotatorNotes T13	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T14	PROC 852 872	continuar la terapia
#9	AnnotatorNotes T14	C2091305; continue current medication; Therapeutic or Preventive Procedure
T15	PROC 157 171	administración
#10	AnnotatorNotes T15	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T16	PROC 446 460	administración
#11	AnnotatorNotes T16	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T17	Date 13 17	2015
T18	Date 137 150	a largo plazo
T19	LIVB 198 217	sujetos pediátricos
#12	AnnotatorNotes T19	C0681850; Study Subject; Group + C0008059; Child; Age Group
T21	Date 426 439	a largo plazo
T22	LIVB 487 506	sujetos pediátricos
#13	AnnotatorNotes T22	C0681850; Study Subject; Group + C0008059; Child; Age Group
T23	LIVB 632 638	sujeto
#14	AnnotatorNotes T23	C0681850; Study Subject; Group
T24	Date 697 709	la semana 52
T25	LIVB 760 766	sujeto
#15	AnnotatorNotes T25	C0681850; Study Subject; Group
T26	LIVB 789 801	investigador
#16	AnnotatorNotes T26	C0035173; Research Personnel; Professional or Occupational Group
A1	Population_data T19 Age
A2	Population_data T22 Age
#17	AnnotatorNotes T1	C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity 
#18	AnnotatorNotes T6	C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity 
#19	AnnotatorNotes T3	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity
#20	AnnotatorNotes T9	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity
T20	Neg_cue 828 830	no
T27	Observation 837 872	candidato para continuar la terapia
A3	Assertion T27 Negated
R1	Overlap Arg1:T3 Arg2:T18	
T28	Quantifier_or_Qualifier 172 180	repetida
#21	AnnotatorNotes T28	C0205341; Repeat; Functional Concept
R2	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T28	
R3	Used_for Arg1:T4 Arg2:T15	
R4	Experiences Arg1:T19 Arg2:T5	
R5	Experiences Arg1:T19 Arg2:T15	
R6	Experiences Arg1:T19 Arg2:T2	
T29	Observation 243 265	finalizaron el estudio
#22	AnnotatorNotes T29	C2732579; Completion of clinical trial; Finding
R8	Before Arg1:T29 Arg2:T1	
R9	Before Arg1:T29 Arg2:T3	
R10	Overlap Arg1:T9 Arg2:T21	
R11	Experiences Arg1:T22 Arg2:T16	
R12	Experiences Arg1:T22 Arg2:T11	
R13	Used_for Arg1:T10 Arg2:T16	
R14	Experiences Arg1:T22 Arg2:T8	
R15	Experiences Arg1:T22 Arg2:T7	
T30	Observation 532 554	finalizaron el estudio
#23	AnnotatorNotes T30	C2732579; Completion of clinical trial; Finding
R17	Before Arg1:T30 Arg2:T6	
R18	Before Arg1:T30 Arg2:T9	
T31	Observation 670 680;710 722	completado el protocolo
#24	AnnotatorNotes T31	C2732579; Completion of clinical trial; Finding
R19	Overlap Arg1:T31 Arg2:T24	
T32	CONC 655 663	incluido
#25	AnnotatorNotes T32	C1512693; Inclusion; Qualitative Concept
R21	Before Arg1:T32 Arg2:T24	
R22	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T27	
R23	Negation Arg1:T20 Arg2:T27	
A4	Assertion T14 Negated
R24	Negation Arg1:T20 Arg2:T14	
R25	Experiences Arg1:T25 Arg2:T14	
T33	Quantifier_or_Qualifier 461 469	repetida
#26	AnnotatorNotes T33	C0205341; Repeat; Functional Concept
R26	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T33	
R27	Used_for Arg1:T2 Arg2:T15	
R7	Used_for Arg1:T7 Arg2:T16	
R28	Used_for Arg1:T8 Arg2:T16	
#27	AnnotatorNotes T18	C0443252; Long-term; Temporal Concept
#28	AnnotatorNotes T21	C0443252; Long-term; Temporal Concept
A5	Experiencer T19 Patient
A6	Experiencer T22 Patient
A7	Experiencer T23 Patient
A8	Experiencer T25 Patient
A9	Experiencer T26 Other
